This webinar introduces key updates in acute ischemic stroke management, focusing on how modern decision‑making integrates time‑sensitive evaluation, advanced imaging, and AI‑supported tools. It also reviews the expanded…
Daniel R. Schimmel, MD, explains how balloon pulmonary angioplasty (BPA) uses balloons and specialized catheters to open narrowed vessels in the lungs to improve circulation and reduce symptoms…
NEW YORK (Reuters Health) – Elevated levels of high-sensitivity C-reactive protein (hsCRP), an inflammatory marker, predicted mortality and myocardial infarction but not stroke in a multiethnic cohort. “Our…
NEW YORK (Reuters Health) – Patients with severe cases of novel H1N1 influenza virus infection (swine flu) are at heightened risk for chest complications, including pulmonary emboli, Michigan…
The following webcasts feature experts in the field of venous thromboembolism (VTE) prevention. Topics cover several aspects of VTE prevention today, including VTE prevalence, patient risk factors, the…
The following webcasts feature experts in the field of venous thromboembolism (VTE) prevention. Topics cover several aspects of VTE prevention today, including VTE prevalence, patient risk factors, the…
The following webcasts feature experts in the field of venous thromboembolism (VTE) prevention. Topics cover several aspects of VTE prevention today, including VTE prevalence, patient risk factors, the…
The following webcasts feature experts in the field of venous thromboembolism (VTE) prevention. Topics cover several aspects of VTE prevention today, including VTE prevalence, patient risk factors, the…
NEW YORK (Reuters Health) – Neoadjuvant treatment with erlotinib (Tarceva), an epidermal growth factor receptor (EGFR) inhibitor, can help downstage bladder cancer to organ-confined disease, thereby increasing the…
NEW YORK (Reuters Health) – Coronary angiography is a recommended screening test for many patients undergoing kidney transplantation and now new research shows that it can be performed…
NEW YORK (Reuters Health) – Deferring percutaneous coronary intervention (PCI) and treating high-risk heart disease patients with optimal medical therapy alone does not increase the risk of death,…
